Oncology Hematology Care Inc-Kenwood

Cincinnati, Ohio, United States
Cancer treatment center in Cincinnati, Ohio
5053 Wooster Rd, Cincinnati, OH 45226

About Oncology Hematology Care Inc-Kenwood


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
76
SWOG Cancer Research Network
33
Alliance for Clinical Trials in Oncology
23
ECOG-ACRIN Cancer Research Group
18
NRG Oncology
4
Gynecologic Oncology Group
3
GOG Foundation
2
Wake Forest University Health Sciences
2
Eastern Cooperative Oncology Group
1
Total Rows: 9

Clinical Trials at Oncology Hematology Care Inc-Kenwood


During the past decade, Oncology Hematology Care Inc-Kenwood conducted 101 clinical trials. In the 10-year time frame, 101 clinical trials started and 64 clinical trials were completed, i.e. on average, 63.4% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 46 clinical trials were completed. i.e. 164.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years15151212131313132020222266002222559912121717Started TrialsCompleted Trails20152016201720182019202020210102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
2009-06-29
2024-07-28
Active, not recruiting
813
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
2009-07-15
2022-02-08
Completed
1,333
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer
2009-08-17
Active, not recruiting
637
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
2010-03-15
Active, not recruiting
117
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery
2010-04-12
Active, not recruiting
341
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
2011-04-01
2023-07-01
Active, not recruiting
1,545

Rows per page:

1–100 of 162

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Oncology Hematology Care Inc-Kenwood" #1 sponsor was "National Cancer Institute (NCI)" with 76 trials, followed by "SWOG Cancer Research Network" with 33 trials sponsored, "Alliance for Clinical Trials in Oncology" with 23 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored and "NRG Oncology" with 18 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Hematology Care Inc-Kenwood" #1 collaborator was "National Cancer Institute (NCI)" with 86 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 76National CancerInstitute (NCI): 76SWOG Cancer ResearchNetwork: 33SWOG Cancer ResearchNetwork: 33Alliance for ClinicalTrials in Oncology: 23Alliance for ClinicalTrials in Oncology: 23ECOG-ACRIN CancerResearch Group: 18ECOG-ACRIN CancerResearch Group: 18NRG Oncology: 4NRG Oncology: 4Gynecologic Oncology Group: 3Gynecologic Oncology Group: 3GOG Foundation: 2GOG Foundation: 2Wake Forest UniversityHealth Sciences: 2Wake Forest UniversityHealth Sciences: 2Eastern CooperativeOncology Group: 1Eastern CooperativeOncology Group: 1

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 86National CancerInstitute (NCI): 86NRG Oncology: 14NRG Oncology: 14Canadian Cancer Trials Group: 6Canadian Cancer Trials Group: 6Genentech, Inc.: 2Genentech, Inc.: 2Astellas Pharma US, Inc.: 1Astellas Pharma US, Inc.: 1Bayer: 1Bayer: 1Biologics, Inc.: 1Biologics, Inc.: 1Brain Science Foundation: 1Brain Science Foundation: 1Cancer PreventionPharmaceuticals, Inc.: 1Cancer PreventionPharmaceuticals, Inc.: 1Division of Cancer Control: 1Division of Cancer Control: 1

Clinical Trials Conditions at Oncology Hematology Care Inc-Kenwood


According to Clinical.Site data, the most researched conditions in "Oncology Hematology Care Inc-Kenwood" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Breast Carcinoma" (7 trials) and "Invasive Breast Carcinoma" (6 trials). Many other conditions were trialed in "Oncology Hematology Care Inc-Kenwood" in a lesser frequency.

Clinical Trials Intervention Types at Oncology Hematology Care Inc-Kenwood


Most popular intervention types in "Oncology Hematology Care Inc-Kenwood" are "Drug" (138 trials), "Other" (100 trials), "Biological" (66 trials), "Procedure" (41 trials) and "Radiation" (16 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (51 trials), "Quality-of-Life Assessment" (41 trials), "Carboplatin" (25 trials), "Computed Tomography" (22 trials) and "Biospecimen Collection" (21 trials). Other intervention names were less common.

Clinical Trials Genders at Oncology Hematology Care Inc-Kenwood


The vast majority of trials in "Oncology Hematology Care Inc-Kenwood" are 137 trials for "All" genders, 21 trials for "Female" genders and 4 trials for "Male" genders.

Clinical Trials Status at Oncology Hematology Care Inc-Kenwood


Currently, there are NaN active trials in "Oncology Hematology Care Inc-Kenwood". undefined are not yet recruiting, 47 are recruiting, 77 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Oncology Hematology Care Inc-Kenwood, 3 suspended trials, and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Oncology Hematology Care Inc-Kenwood, 6 "Phase 1" clinical trials were conducted, 88 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 88Phase 2: 88Phase 3: 75Phase 3: 75Phase 1: 6Phase 1: 6Not Applicable: 3Not Applicable: 3

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 77Active, not recruiting: 77Recruiting: 47Recruiting: 47Completed: 29Completed: 29Terminated: 6Terminated: 6Suspended: 3Suspended: 3